med_depart1

Eliava Institute

Discover the Eliava Institute in Tbilisi, the historic pioneer of bacteriophage research and the world's foremost clinical center for phage therapy.
Read More
med_depart1

Phage therapy and cystic fibrosis

Phage therapy provides a targeted treatment for cystic fibrosis patients facing antibiotic-resistant lung infections. It uses bacteriophages to specifically attack pathogens like Pseudomonas aeruginosa, potentially reducing infection rates and improving lung health.
Read More
med_depart1

Treatment of Multi-Resistant Urinary Tract Infections

Phage therapy offers a groundbreaking approach to treating bacterial infections, particularly those that are resistant to traditional antibiotics. This method utilizes bacteriophages, viruses that specifically infect and destroy bacteria, to selectively target and eliminate pathogenic bacteria while leaving beneficial bacteria unharmed. By harnessing the natural predatory capabilities of phages, this therapy can effectively combat infections in a way that reduces the risk of antibiotic resistance. Ideal for treating a variety of bacterial ailments, from skin infections to more severe systemic infections, phage therapy is gaining recognition as a vital tool in the fight against increasingly drug-resistant bacterial strains.
Read More
med_depart1

Treatment of Crohn’s Disease

Phage therapy is an emerging treatment for Crohn's disease, focusing on restoring balance to the gut microbiota. This method targets and eliminates specific pathogenic bacteria, potentially reducing gastrointestinal inflammation without affecting beneficial bacteria. Although still in early stages, with most research conducted on animal models, Georgian clinicians are at the forefront, applying phage therapy in clinical settings to manage Crohn's symptoms effectively.
Read More